Search results for Rozanolixizumab
Rozanolixizumab, Abbexa, abx831390
Rozanolixizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting FCGRT, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Rozanolixizumab is under investigation in clinical trial NCT03861481 (A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy).
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Rozanolixizumab Biosimilar - Research Grade, ichor.bio, ICH5051
Detects human FcRn. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Rozanolixizumab.
Host
CHO cells
Reactivity
Human
Applications
Conjugation
Research Grade Rozanolixizumab (HX061026), abinScience, HX061026
Host
Humanized
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Please provide the required information below so that we can quickly source your products.